Engineering Clinically Relevant Probiotics with Switchable "Nano-Promoter" and "Nano-Effector" for Precision Tumor Therapy.
Cao F, Jin L, Zhang C, Gao Y, Qian Z, Wen H, Yang S, Ye Z, Hong L, Yang H, Tong Z, Cheng L, Ding Y, Wang W, Yu G, Mao Z, Chen X.
Cao F, et al. Among authors: ye z.
Adv Mater. 2024 Feb;36(5):e2304257. doi: 10.1002/adma.202304257. Epub 2023 Dec 4.
Adv Mater. 2024.
PMID: 37788635